Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EBOS Group Limited ( (AU:EBO) ) has shared an update.
EBOS Group Limited has declared an interim cash distribution on its ordinary shares funded from retained earnings, with total payments of about NZD 116.9 million and a net cash dividend of NZD 0.57 per share, partially imputed at 8.86 percent. The record date is 6 March 2026, with shares trading ex-dividend from 5 March and payment scheduled for 27 March, providing shareholders with a significant interim return.
The company will again operate its dividend reinvestment plan, issuing new shares at a 2 percent discount to the volume weighted average price calculated between 9 and 13 March 2026, with a final strike price to be announced on 18 March. This structure allows investors to increase their holdings at a discount while enabling EBOS to conserve cash and strengthen its capital base through equity funding rather than relying solely on cash outflows.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$26.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited is a listed company operating in the healthcare and animal care sectors, supplying pharmaceuticals, medical products and related services across Australasian markets. The group generates earnings that support regular shareholder distributions and offers a dividend reinvestment plan to fund ongoing growth through new share issuance.
Average Trading Volume: 136,505
Technical Sentiment Signal: Sell
Current Market Cap: A$4.29B
For an in-depth examination of EBO stock, go to TipRanks’ Overview page.